VENTRICULAR SEPTAL DEFECT: A COMPREHENSIVE LITERATURE REVIEW OF PATHOPHYSIOLOGY, DIAGNOSIS, AND TREATMENT
Authors:
- Wiktoria SzumlińskaWSWiktoria Szumlińska
- Julia ProcykJPJulia Procyk
- Marta Danuta CendrowskaMCMarta Danuta Cendrowska
- Aleksandra KlukowskaAKAleksandra Klukowska
- Beata ChoromańskaBCBeata Choromańska
- Karolina StępieńKSKarolina Stępień
- Justyna BerentJBJustyna Berent
- Paulina RzepaPRPaulina Rzepa
- Barbara PonitkaBPBarbara Ponitka
- Julia MaszewskaJMJulia Maszewska
- Szymon MilnerowiczSMSzymon Milnerowicz
- Łukasz BrzostŁBŁukasz Brzost
Open Access
- 24 December 2025
- journal article
- review article
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (4(48))
Abstract
Background: Ventricular septal defect (VSD) is the most prevalent congenital heart defect, characterized by an abnormal communication between the ventricles, leading to a left-to-right shunt. Its clinical spectrum ranges from asymptomatic small defects to large shunts causing heart failure, pulmonary hypertension, or Eisenmenger syndrome. Early diagnosis and appropriate management are critical to prevent long-term complications. Methods: This literature review synthesizes current evidence on the classification, pathophysiology, diagnostic modalities, treatment options, and long-term outcomes of VSD. A comprehensive analysis of peer-reviewed articles and clinical guidelines was conducted to present up-to-date insights into the multidisciplinary approach to VSD care. Results: Anatomical subtypes of VSD vary in clinical significance, risk of complications, and management strategies. Advances in imaging, particularly echocardiography and cardiac MRI, have improved diagnostic precision. While small defects often resolve spontaneously and are managed conservatively, large or symptomatic defects may require surgical or transcatheter closure. Surgical repair remains the standard for most cases, but selected muscular and perimembranous defects can be treated percutaneously. Long-term follow-up is essential due to risks of arrhythmias, conduction block, residual shunts, or valve dysfunction. Emerging technologies—including biodegradable devices, minimally invasive surgery, and experimental gene therapy—may reshape future management paradigms. Conclusions: VSD management requires individualized, anatomy-guided decision-making supported by multidisciplinary expertise. Technological progress has expanded therapeutic options, yet lifelong surveillance remains necessary to mitigate late complications and optimize outcomes.Keywords
This publication has 38 references indexed in Scilit:
- Spontaneous closure of large ventricular septal defect after aortoplasty and pulmonary artery banding in an infant with interrupted aortic archAsian Journal of Surgery, 2023
- Transfemoral Perimembranous Ventricular Septal Defect Device Closure in Infants Weighing ≤ 10 kgPediatric Cardiology, 2023
- Hybrid Closure of Ventricular Septal Defect and Implantation of Systemic Right Ventricular Assist DeviceESC Heart Failure, 2022
- Prenatally diagnosed isolated perimembranous ventricular septal defect: Genetic and clinical implicationsPrenatal Diagnosis, 2022
- Post MI Ventricular Septal Defect Treated by Percutaneous Implantation of Figulla Flex ASD OccluderJACC: Cardiovascular Interventions, 2021
- The Ongoing — and Resurgent — Challenge of Post-Infarct Ventricular Septal Defect ManagementCardiovascular Revascularization Medicine, 2020
- Progression of Aortic Regurgitation After Subarterial Ventricular Septal Defect Repair: Optimal Timing of the OperationPediatric Cardiology, 2019
- Prediction of spontaneous closure of ventricular septal defect and guidance for clinical follow‐upClinical Cardiology, 2019
- Closure Is Not CorrectionJACC, 2015
- Fibrous obstruction within the left ventricular outflow tract associated with ventricular septal defect: A pathologic studyJACC, 1995